Potential coronavirus drugs, illustration

Numéro d’image : 13224181
Potential coronavirus drugs, illustration
Potential coronavirus drugs, illustration. Clockwise from upper left are molecules of the nucleotide analogue remdesivir, the antiretroviral protease inhibitor lopinavir, the protease inhibitor camostat mesilate and the antimalaria and antiviral drug chloroquine. At centre is a SARS-CoV-2 coronavirus particle. These drugs are being investigated as treatments for covid-19, the respiratory infection caused by the Sars-CoV-2 (previously 2019-nCoV) virus. Camostat and lopinavir block the virus from entering human cells. Remdesivir disrupts the production of RNA (ribonucleic acid), the coronavirus genome and so stops the virus from replicating. Chloroquine's mechanism of action against the virus remains unclear. Sars-CoV-2 was first identified in Wuhan, China, in December 2019. As of earl April 2020, the virus has spread to many countries worldwide and has been declared a pandemic. Over 1.1 million have been infected with over 62,000 deaths.
Licence : Droits gérés
Crédit: Science Photo Library / Gaertner, Juan
Taille de l’image : 8000 px × 6000 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;